Osteoporosis in Primary Biliary Cirrhosis: A Randomized Trial of the Efficacy and Feasibility of Estrogen/Progestin
- 1 June 2006
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 51 (6) , 1103-1112
Abstract
The optimal therapy for the prevention and treatment of osteoporosis in primary biliary cirrhosis (PBC) is unknown. Hormone replacement therapy (HRT) prevents osteoporosis, but may promote cholestasis. We performed a double-blind, randomized, placebo-controlled trial of transdermal estrogen/progestin in postmenopausal women with PBC. The 24-month study enrolled 31 patients, but trial uptake was limited and treatment arm dropout was significant. Placebo-treated patients had a higher percentage loss in femoral neck bone mineral density than actively treated patients (−3.76 ± 1.37% versus 0.21 ± 1.01%, respectively, P = .058). New fractures occurred in 2 patients on placebo, and in no patients on treatment. The mean monthly increase in bilirubin was not significantly different between groups, but individual data suggest HRT may worsen cholestasis. In conclusion, women with PBC have strong feelings about HRT, and recruitment for this intervention is difficult. Transdermal estrogen/progestin likely provides protection against bone loss in PBC patients, but may worsen cholestasis.Keywords
This publication has 55 references indexed in Scilit:
- Bone metabolism in advanced cholestatic liver disease: Analysis by bone histomorphometryHepatology, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Duration and severity of the disease but not menopausal status are the main risk factors for osteoporosis in primary biliary cirrhosisJournal of Hepatology, 2002
- WEIGHING THE CONS AND PROS: WOMEN'S REASONS FOR DISCONTINUING HORMONE REPLACEMENT THERAPYHealth Care for Women International, 2002
- Hormone Replacement TherapySocial Work in Health Care, 1999
- Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference?Hepatology, 1995
- Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosisBone, 1993
- Sodium fluoride prevents bone loss in primary biliary cirrhosisJournal of Hepatology, 1992
- Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatmentJournal of Hepatology, 1991
- Estrogen-Induced Cholestasis: Clues to Pathogenesis and TreatmentHepatology, 1983